Colorectal cancer, the abnormal growth of cancerous cells in the large intestine or the rectum, is one of the most common ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

A genetic risk score can help predict which women will develop invasive breast cancer after abnormal cells have been found in their breast tissue, researchers said. Women who scored high on the ...

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...

BRAF-positive non-small cell lung cancer (NSCLC) treatments can use the BRAF biomarker to provide effective, targeted treatment for this subset of lung cancer. BRAF-positive NSCLC is an uncommon or ...

ANKL is a rare and aggressive type of blood cancer affecting a type of white blood cell called natural killer (NK) cells. In ANKL, the NK cells are abnormal and multiply out of control, crowding out ...

Some tumours are cancerous, but not all cancers can form tumours. How are cancers different from the abnormal pumps you ...

Rising incidence rates, high recurrence, and limited curative options are accelerating demand for innovative glioblastoma ...

A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has developed a promising new therapeutic strategy for fibrodysplasia ossificans ...